Topical CBD Formulation with Adjuvants for Bioavailability and Low THC

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current CBD formulations often contain significant amounts of THC, which are undesirable due to legal classifications and complications, and pure cannabidiol has low bioavailability and a narrow therapeutic dose range, limiting its therapeutic applications.

Innovation Solution

Development of topical CBD products with sweet almond oil, hemp seed oil, shea butter, and other adjuvants that minimize THC content below 0.3% and enhance bioavailability, including massage lotions and creams with specific ingredient ratios to widen the therapeutic dose range.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If CBD oil is used in topical treatments, then therapeutic applications are improved, but THC content increases causing legal complications

Engineering Contradiction:

Improvetherapeutic effectivenessVSAvoidTHC content

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and isolates cannabidiol (CBD) from the cannabis plant material, separating it from tetrahydrocannabinol (THC) and other unwanted components. This extraction process allows the formulation to contain therapeutic CBD while minimizing or eliminating THC content to below detectable levels or below the 0.3% legal threshold, thereby resolving the contradiction between therapeutic effectiveness and legal compliance.

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent formulates CBD into specific topical preparations (lotions, creams, ointments, balms) with localized properties optimized for skin application. By creating formulations with specific vehicle compositions, concentrations, and delivery mechanisms tailored for topical use, the patent achieves effective local delivery of CBD to target areas while maintaining THC-free status, thus resolving the contradiction between therapeutic reliability and harmful THC presence.

Inventive Principle:

Principle #3Local quality

2Device complexity

If pure cannabidiol is used, then therapeutic applications are simplified, but bioavailability decreases and therapeutic dose range narrows

Engineering Contradiction:

Improveformulation simplicityVSAvoidbioavailability

Core Design Contradiction:

Device complexityVSReliability

Solution Approach 1:

The patent creates composite topical formulations by combining CBD with various vehicles (oils, butters, waxes), penetration enhancers, and adjuvants. These composite materials improve the bioavailability and therapeutic effectiveness of pure CBD through mechanisms such as enhanced skin penetration, sustained release, and synergistic effects from combination ingredients, thereby resolving the contradiction between formulation simplicity and bioavailability reliability.

Inventive Principle:

Principle #40Composite materials

Solution Approach 2:

The patent optimizes multiple parameters including CBD concentration ranges, vehicle composition ratios, pH levels, and physical state (ointment vs. lotion) to maximize bioavailability and widen the therapeutic dose range. By systematically adjusting these parameters, the patent transforms pure CBD into highly effective topical preparations with improved absorption and expanded therapeutic windows, resolving the contradiction between simplicity and reliability.

Inventive Principle:

Principle #35Parameter changes

3Reliability

If THC is present above 0.3%, then certain therapeutic effects may be enhanced, but legal classification as controlled substance applies

Engineering Contradiction:

Improvetherapeutic effectVSAvoidlegal usability

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent converts the potential harm of THC presence by using selective extraction and purification methods that eliminate THC while preserving CBD. The patent also leverages the legal distinction between hemp-derived CBD (THC < 0.3%) and marijuana-derived products, transforming what could be a legal liability into a market advantage by creating THC-free formulations that can be sold nationwide without controlled substance restrictions, thereby resolving the contradiction between therapeutic effect and legal usability.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS11559499B1Lotion and tinctures containing CBD oil including preparation and use thereof

Publication Date: 2023.01.24 LUTOVSKY GREG

AI summary

Here is presented a novel formulation of a topical treatment containing cannabidiol (CBD), as well as shea butter, cocoa butter coconut oil, aloe vera, body butter, lavender, lemongrass and tangerine. Such formulation may be applied to the skin in a variety of applications. The formulations are made with nearly no THC. Formulations include massage oil, pain relief cream, gardener's relief cream, warming cream, hand and body lotion grip, massage lotion glide and a gardener's relief oil.